Search
for
Sort by
Research 30 of 1000+
- Post-finasteride syndrome
- Adverse events with finasteride or dutasteride: FAERS
- Síndrome postfinasterida y disfunción eréctil. Caso clínico y revisión de la literatura
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- Post-finasteride syndrome – does it really exist?
- Discriminating in favour of or against men with increased risk of finasteride-related side effects?
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Post-finasteride syndrome
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- Hormone therapy in acne
- Common urologic diseases in older men and their treatment: how they impact fertility
- Post-finasteride syndrome: An emerging clinical problem
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- ANAIS DO I CONGRESSO MÉDICO DE FORMOSA - COMEF
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Risk of rhabdomyolysis from 5-α reductase inhibitors
- Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target
- Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Clinical use of 5α-reductase inhibitors
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Inhibition of 5α Reductase Impairs Cognitive Performance, Alters Dendritic Morphology and Increases Tau Phosphorylation in the Hippocampus of Male 3xTg-AD Mice
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- Post-SSRI sexual dysfunction & other enduring sexual dysfunctions
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1